bioRxiv · 10.1101/2025.06.03.657117
Examining the Role of Extrachromosomal DNA in 1,216 Lung Cancers
Abstract
The role of extrachromosomal DNA (ecDNA) in lung cancer, particularly in subjects who never smoked (LCINS), remains unclear. Examination of over 1200 whole-genome-sequenced lung cancers identified ecDNA in 18.9% of patients. Recurrent amplification of MDM2 and other oncogenes via ecDNA possibly drives a LCINS subset. Tumors harboring ecDNA showed worse overall survival than tumors harboring other focal amplifications. A strong association with whole-genome doubling suggests most ecDNA reflects genomic instability in treatment-naive lung cancer.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Khandekar, A., Hoang, P. H., Luebeck, J., Diaz-Gay, M., Zhao, W., McElderry, J. P., Hartman, C., Miraftab, M., Lee, O. W., Barnao, K. M., Bergstrom, E. N., Yang, Y., Nowak, M. A., Rothman, N., Homer, R., Yang, S.-R., Lan, Q., Wedge, D. C., Yang, L., Chanock, S. J., Zhang, T., Alexandrov, L. B., Landi, M. T.. 2025-06-07. Examining the Role of Extrachromosomal DNA in 1,216 Lung Cancers. https://doi.org/10.1101/2025.06.03.657117
Cite the original work for its findings. Save a collection to share your selection of sources.